Older people have a strong immune response to Oxford’s vaccine, raising hopes that it will protect all sectors of society.
Although the research cannot prove that the vaccine protects against disease, it did show that even in people over 70 it elicited a robust antibody and T-cell immune response. The findings come from a previously unreleased analysis of early-stage human trials, looking specifically at volunteers aged 56 and over.
“This marks a key milestone and reassures us that the vaccine is safe for use and induces strong immune responses in both parts of the immune system in all adult groups,” said Andrew Pollard, from Oxford University, who announced the findings. The elderly are most at risk of suffering from severe Covid but there has been
